Amicus Therapeutics Announces Positive Progress of Three Lead Clinical Programs and General Outlook

January 12, 2009

... focuses on meeting the needs of the specialist physician. Shire focuses its business on attention deficit and hyperactivity disorder (ADHD), human genetic therapies (HGT) and gastrointestinal (GI) diseases as well as opportunities in other ...

Written by Healthcare Industry Today: ADHD News · Filed Under ADHD